Results
97
97 companies
Maxigen Biotech
Market Cap: NT$4.0b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$45.80
7D
-0.1%
1Y
1.0%
Formosa Pharmaceuticals
Market Cap: NT$4.8b
A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.
6838
NT$32.30
7D
3.2%
1Y
-39.4%
PhytoHealth
Market Cap: NT$3.2b
Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan.
4108
NT$15.85
7D
-0.9%
1Y
-21.9%
Eusol BiotechLtd
Market Cap: NT$1.1b
Focuses on research and development of new biotech drugs for sleep disorders.
6652
NT$7.80
7D
-1.1%
1Y
-12.8%
TCM Biotech International
Market Cap: NT$3.3b
A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.
4169
NT$57.10
7D
-1.2%
1Y
8.6%
HeXun Biosciences
Market Cap: NT$3.7b
Engages in the research and development of stem cell and treatments in Taiwan.
6986
NT$81.00
7D
-6.0%
1Y
47.3%
Advagene Biopharma
Market Cap: NT$1.3b
Engages in the research and development of vaccine technology and related products in Taiwan.
6709
NT$21.40
7D
-2.7%
1Y
9.7%
EirGenix
Market Cap: NT$23.2b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$77.70
7D
0.6%
1Y
-9.2%
Shine-On BioMedicalLtd
Market Cap: NT$3.3b
Research, develops, and manufactures anti-cancer related drug products.
6926
NT$65.20
7D
0.6%
1Y
0.5%
PharmaEngine
Market Cap: NT$15.2b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$104.50
7D
-1.9%
1Y
8.0%
Synmosa Biopharma
Market Cap: NT$14.4b
A specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.
4114
NT$34.15
7D
0%
1Y
-3.2%
CHO Pharma
Market Cap: NT$11.4b
Engages in research and development of biotechnology in Taiwan.
6586
NT$53.20
7D
-2.2%
1Y
-10.0%
Savior Lifetec
Market Cap: NT$6.5b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$20.80
7D
2.2%
1Y
8.9%
BIONET Therapeutics
Market Cap: NT$3.7b
A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.
7808
NT$53.50
7D
-2.7%
1Y
n/a
ScinoPharm Taiwan
Market Cap: NT$17.9b
Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.
1789
NT$22.50
7D
-2.0%
1Y
-13.6%
Sinew Pharma
Market Cap: NT$3.5b
A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.
6634
NT$49.60
7D
1.2%
1Y
-26.1%
Oneness Biotech
Market Cap: NT$34.4b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.
4743
NT$72.20
7D
-3.9%
1Y
-55.7%
Ever Supreme Bio Technology
Market Cap: NT$14.6b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells.
6712
NT$176.50
7D
-0.8%
1Y
-8.8%
Alar Pharmaceuticals
Market Cap: NT$9.8b
A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.
6785
NT$146.50
7D
0%
1Y
-51.3%
TaiwanJ Pharmaceuticals
Market Cap: NT$726.7m
A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.
6549
NT$9.12
7D
1.0%
1Y
-32.9%
Lukas Biomedical
Market Cap: NT$1.1b
Engages in the wholesale and retail of cosmetics in Taiwan.
6814
NT$25.50
7D
1.2%
1Y
-17.7%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.3b
Standard Chemical & Pharmaceutical Co. Ltd.
1720
NT$62.70
7D
-0.6%
1Y
-3.8%
PharmaEssentia
Market Cap: NT$186.5b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$564.00
7D
-0.4%
1Y
77.4%
BRIM Biotechnology
Market Cap: NT$3.7b
A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.
6885
NT$28.10
7D
-3.6%
1Y
-17.2%
TaiRx
Market Cap: NT$3.0b
Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.
6580
NT$25.75
7D
-7.9%
1Y
1.8%
Vectorite Biomedical
Market Cap: NT$595.3m
Engages in the research and development of biotechnology in Taiwan and internationally.
4170
NT$13.45
7D
-1.5%
1Y
-14.9%
Senhwa Biosciences
Market Cap: NT$3.7b
A drug development company, engages in the development of new drugs and targeted agents.
6492
NT$41.55
7D
-2.2%
1Y
-3.5%
GlycoNex Incorporation
Market Cap: NT$2.6b
Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.
4168
NT$23.85
7D
-1.0%
1Y
-3.0%
Pharmosa Biopharm
Market Cap: NT$7.0b
A biotechnology company, focuses on developing drugs in Taiwan.
6875
NT$53.40
7D
0.8%
1Y
-42.0%
Medigen Vaccine Biologics
Market Cap: NT$17.7b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$53.80
7D
-3.9%
1Y
3.5%
DV Biomed
Market Cap: NT$1.4b
Manufactures and sells medical-grade skin care products in Taiwan and China.
6539
NT$66.00
7D
3.8%
1Y
-49.5%
Abnova (Taiwan)
Market Cap: NT$1.8b
Manufactures and sells various recombinant proteins and antibodies.
4133
NT$30.05
7D
0.3%
1Y
-5.9%
Lumosa Therapeutics
Market Cap: NT$34.5b
A clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan, Asia, the Americas, and Europe.
6535
NT$205.50
7D
-1.9%
1Y
14.2%
UnicoCell Biomed
Market Cap: NT$4.1b
Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.
6794
NT$70.00
7D
-1.3%
1Y
-19.5%
YungShin Global Holding
Market Cap: NT$15.0b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics in Taiwan, the United States, Mainland China, and Japan.
3705
NT$55.50
7D
-1.2%
1Y
16.5%
SynCore BiotechnologyLtd
Market Cap: NT$1.2b
Engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan.
4192
NT$33.90
7D
-1.5%
1Y
-9.5%